Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 119 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2010Medication errors - what is the best way to reduce their impact on patients' health?Karnon, J.
2016What are we paying for? A cost-effectiveness analysis of patented denosumab and generic alendronate for postmenopausal osteoporotic women in AustraliaKarnon, J.; Shafie, A.; Orji, N.; Usman, S.
2001A model for analyzing the cost of the main clinical events after lung transplantationSharples, L.; Taylor, G.; Karnon, J.; Caine, N.; Buxton, M.; McNeil, K.; Wallwork, J.
2002Planning the efficient allocation of research funds: An adapted application of a non-parametric Bayesian value of information analysisKarnon, J.
2003The role of modelling in prioritising and planning clinical trialsChilcott, J.; Brennan, A.; Booth, A.; Karnon, J.; Tappenden, P.
2004Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis.Karnon, J.; Peters, J.; Chilcott, J.; McGoogan, E.; Brewer, N.
2006Cost effectiveness of extended adjuvant letrozole in postmenopausal women after adjuvant tamoxifen therapy: The UK perspectiveKarnon, J.; Delea, T.; Johnston, S.; Smith, R.; Brandman, J.; Sung, J.; Goss, P.
2003Efficiency of alternative policy options for screening for developmental dysplasia of the hip in the United KingdomBrown, J.; Dezateux, C.; Karnon, J.; Parnaby, A.; Arthur, R.
2001Economic evaluation alongside n-of-1 trials: getting closer to the marginKarnon, J.; Qizilbash, N.
2008Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspectiveDelea, T.; El-Ouagari, K.; Karnon, J.; Sofrygin, O.